Imaging agent for clearer tumor removal in oral cancer surgery
Part of Cancer clinical trials.
This study tests a new imaging agent that helps surgeons see oral tumors more clearly during surgery. It aims to improve the accuracy of tumor removal.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You must have oral cancer or a benign tumor in the mouth.
- You must be scheduled for surgery to remove the tumor.
- You must not have any other type of cancer.
- You must not have any serious health conditions that would prevent surgery.
- You must be able to give informed consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combination of two drugs (sacituzumab govitecan and toripalimab) given before surgery to shrink advanced oral cavity tumors. The goal is to see if this approach helps make surgery more effective and improves outcomes.
This trial tests a special imaging dye that lights up bladder cancer during surgery, helping doctors see and remove it more precisely. It may help ensure all cancer is removed while sparing healthy tissue.
This trial tests a new imaging method that helps surgeons see bladder cancer clearly during surgery, so they can remove it precisely. It may help ensure all cancer is removed and reduce the chance of leaving any behind.
This trial tests whether a special dye called ICG, which glows under infrared light, can help surgeons better see and remove bone and soft tissue tumors during surgery. The goal is to make the removal more precise and safe.
This study tests whether a special dye (ICG) injected before surgery can help surgeons see head and neck cancer more clearly during the operation. It is for people with squamous cell carcinoma who are at risk of their cancer returning and are scheduled for surgery.
This trial uses a special dye called indocyanine green (ICG) during surgery to make giant cell bone tumors glow, helping doctors remove them more accurately. It may lead to better surgical outcomes for people with this tumor type.
Hear when a new Diagnosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.